What is the average price target for CABOT CORP (CBT) stock?
12 analysts have analysed CBT and the average price target is 78.03 USD. This implies a price increase of 14.87% is expected in the next year compared to the current price of 67.93.
NYSE:CBT • US1270551013
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CABOT CORP (CBT).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-05 | Mizuho | Downgrade | Outperform -> Neutral |
| 2026-02-05 | UBS | Maintains | Neutral -> Neutral |
| 2026-01-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-28 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-11-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-03 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-08-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-07 | UBS | Maintains | Neutral -> Neutral |
| 2025-02-21 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-01-07 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-11-11 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-11-05 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-08-07 | JP Morgan | Maintains | Neutral -> Neutral |
| 2024-08-06 | UBS | Maintains | Neutral -> Neutral |
| 2024-05-07 | Mizuho | Maintains | Buy -> Buy |
| 2024-05-07 | UBS | Maintains | Neutral -> Neutral |
| 2024-04-18 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-03-27 | Mizuho | Initiate | Buy |
| 2024-01-08 | UBS | Downgrade | Buy -> Neutral |
| 2023-12-14 | UBS | Maintains | Buy -> Buy |
| 2023-11-07 | UBS | Maintains | Buy -> Buy |
| 2023-08-11 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-08-08 | Credit Suisse | Maintains | Outperform -> Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.931B -9.03% | 3.994B 1.60% | 3.713B -7.04% | 3.599B -3.07% | 3.703B 2.89% | 3.836B 3.59% | 4.116B 7.30% | |
| EBITDA YoY % growth | 673M -6.27% | 765M 13.67% | 775M 1.31% | 738.06M -4.77% | 782.08M 5.96% | 826.3M 5.65% | N/A | |
| EBIT YoY % growth | 529M -7.52% | 614M 16.07% | 621M 1.14% | 567.4M -8.63% | 605.38M 6.69% | 643.29M 6.26% | 727.2M 13.04% | |
| Operating Margin | 13.46% | 15.37% | 16.73% | 15.77% | 16.35% | 16.77% | 17.67% | |
| EPS YoY % growth | 5.38 -14.06% | 7.06 31.23% | 7.26 2.83% | 6.33 -12.86% | 7.02 10.97% | 7.71 9.76% | 8.79 14.03% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.48 -22.16% | 1.65 -12.97% | 1.71 0.48% | 1.64 7.11% | 1.91 29.23% | 1.87 13.15% | 1.83 7.02% | 1.60 -2.62% | 1.95 1.98% | 2.04 9.04% | 1.90 3.87% |
| Revenue Q2Q % growth | 909.78M -2.80% | 914.01M -0.97% | 882.22M -1.87% | 893.85M 5.28% | 981.53M 7.89% | 962.2M 5.27% | 934.93M 5.97% | 914.99M 2.37% | 1.005B 2.39% | 985.02M 2.37% | 957.07M 2.37% |
| EBITDA Q2Q % growth | 174.61M -26.32% | 189.89M -32.42% | 188M -35.40% | 190.03M 11.78% | 207.38M 18.77% | 205.14M 8.03% | 199.85M 6.30% | 189.82M -0.11% | 213.62M 3.01% | 218.05M 6.29% | 207.19M 3.67% |
| EBIT Q2Q % growth | 132.06M -18.48% | 147.24M -11.83% | 145.36M 6.10% | 136.56M 5.86% | 159.01M 20.41% | 163.2M 10.84% | 151.93M 4.52% | 144.47M 5.79% | 168.27M 5.82% | 172.7M 5.82% | 161.84M 6.52% |
All data in USD
12 analysts have analysed CBT and the average price target is 78.03 USD. This implies a price increase of 14.87% is expected in the next year compared to the current price of 67.93.
CABOT CORP (CBT) will report earnings on 2026-05-04, after the market close.
The consensus EPS estimate for the next earnings of CABOT CORP (CBT) is 1.48 USD and the consensus revenue estimate is 909.78M USD.
The expected long term growth rate for CABOT CORP (CBT) is 0.24%.